Market Cap 9.22B
Revenue (ttm) 1.22B
Net Income (ttm) 73.40M
EPS (ttm) N/A
PE Ratio 34.45
Forward PE 35.52
Profit Margin 6.02%
Debt to Equity Ratio 0.15
Volume 254,301
Avg Vol 1,896,008
Day's Range N/A - N/A
Shares Out 155.81M
Stochastic %K 65%
Beta 1.46
Analysts Strong Sell
Price Target $69.08

Company Profile

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth f...

Industry: Biotechnology
Sector: Healthcare
Phone: 612 379 8854
Fax: 612 656 4400
Address:
614 McKinley Place N.E., Minneapolis, United States
NuNavigator
NuNavigator Dec. 26 at 6:40 AM
$TECH This name increasingly trades on execution rhythm rather than speculation about possibilities. Governance alignment matters more at this stage. Operational wins could gradually shift expectations upward. Execution precision is the primary catalyst from here.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 2:34 PM
$TECH: Current market context shows a bearish trend, with the last close at $59.19 and an RSI of 33.58 indicating oversold conditions. The price is below both the 30-day MA of $60.51 and the 50-day MA of $60.97, reinforcing the downward bias. The 60-day high of $66.96 and low of $54.20 highlight a significant range, suggesting potential for a rebound. Actionable Trade Alert: - Suggested Entry: $59.50 (slightly above last close to confirm upward movement) - Stop Loss: $54.00 (below the 60D low for risk management) - Take Profit Targets: 1. $62.00 (10% ROI) 2. $64.00 (approximately 12.5% ROI) 3. $69.00 (16.5% ROI) With the ATR at $1.86, the targets are achievable within the volatility range. A potential rebound from oversold conditions could drive price towards these targets. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 25 at 9:12 AM
$TECH RSI: 33.58, MACD: -0.6960 Vol: 2.57, MA20: 60.47, MA50: 60.93 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 4:28 PM
$TECH: The current market context shows a stock trading at $57.1, significantly below its 60D high of $66.96, indicating potential for upward movement. The RSI at 23.05 suggests the stock is oversold, which typically signals a reversal opportunity. The 30-day moving average (MA30) at $60.39 and the 50-day moving average (MA50) at $61.00 further support a bullish bias as the price is below these averages, indicating potential resistance levels. Actionable Trade Plan: - Suggested Entry: $57.1 - Stop Loss: $54.0 (3.8% below entry) - Take Profit Targets: 1. $61.0 (6.8% gain) 2. $64.0 (12.5% gain) 3. $66.0 (15.8% gain) With a focus on the potential for a rebound given the oversold RSI and proximity to resistance levels, this trade plan aims for a minimum of 15.8% ROI at the third target. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 3:15 AM
$TECH: Current market context shows a significant downward pressure with the last close at $57.44, and an RSI of 21.06 indicating oversold conditions. The stock is trading below its 30-day MA of 60.62 and 50-day MA of 61.11, suggesting a bearish trend. However, the extreme RSI indicates a potential reversal opportunity. Directional bias leans towards a bullish reversal given the oversold RSI and proximity to the 60D low of $50.13. Suggested entry point is at $57.44. Set a stop loss at $54.00 to manage risk. Take profit targets are as follows: 1. TP1 at $60.00 (5% gain) 2. TP2 at $63.00 (10% gain) 3. TP3 at $67.00 (16.67% gain) Target 3 provides a potential ROI of over 17%. Monitor price action closely for signs of reversal. Trade Plan: Buy at $57.44, SL at $54.00, TP1 at $60.00, TP2 at $63.00, TP3 at $67.00. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 15 at 6:48 AM
$TECH: Current market context shows a recent close at $58.51, with an RSI of 41.33 indicating potential for upward momentum as it is below 50. The stock is trading below its 30-day MA of 60.88 and 50-day MA of 61.29, suggesting bearish sentiment in the short term. However, the price is closer to the 60-day low of 50.13, indicating a potential rebound opportunity. Directional bias leans bullish as the stock may be due for a correction towards its recent highs. Suggested entry is at $58.51. Set a stop loss at $56.46 (1 ATR below the entry). Take Profit Targets: 1. TP1 at $60.00 (4% gain) 2. TP2 at $62.00 (6.5% gain) 3. TP3 at $68.50 (17% gain) This trade plan provides a clear path with a risk-reward ratio favorable for potential gains, especially with the third target achieving over 17% ROI. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 11 at 11:42 PM
$TECH Trade Alert: Market Context: The last close was $60.59, with an RSI of 55.13 indicating a neutral momentum, suggesting potential for upward movement. The stock is currently trading below its 30-day (MA30) and 50-day moving averages (MA50), which are at $60.97 and $61.37 respectively. The 60-day high of $66.96 provides a resistance level, while the low of $50.13 serves as a support level. Directional Bias: Given the RSI is above 50 but below 60, and the proximity to the MA30, we anticipate a bullish trend as it approaches the moving averages. Trade Plan: - Suggested Entry: $60.75 (slightly above last close) - Stop Loss: $58.00 (below recent support) - Take Profit Targets: - Target 1: $63.00 (5% gain) - Target 2: $65.00 (7.5% gain) - Target 3: $71.00 (17% gain) This plan allows for a structured approach with a favorable risk-reward ratio. https://privateprofiteers.com
0 · Reply
JackDarwin
JackDarwin Dec. 11 at 1:26 PM
$TECH Bullish Tweezer Candlestick Pattern Formed
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Dec. 11 at 11:41 AM
$TECH Bio-Techne's Lunaphore Collaborates With Wyss Center For Bio And Neuroengineering To Develop Automated Workflow For Simultaneous RNA And Protein Detection In 3D Specimens
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 3:45 AM
$TECH: Current market context shows the last close at $58.82, with an RSI of 51.95 indicating neutral momentum. The price is below both the 30-day MA of $61.12 and the 50-day MA of $61.25, suggesting a bearish trend in the short term. However, the price is also above the 60-day low of $50.13, providing a potential support level. Directional bias leans slightly bearish due to the moving averages, but the neutral RSI suggests potential for a reversal. Suggested trade plan: - Entry: $58.82 - Stop Loss: $56.74 (1 ATR below entry) - Take Profit Targets: 1. $61.00 (3.73% gain) 2. $63.00 (7.43% gain) 3. $68.50 (16.52% gain) Target 3 offers a potential ROI of over 17%. Monitor the price action closely as it approaches these levels. https://privateprofiteers.com
0 · Reply
Latest News on TECH
Bio-Techne to Present at Upcoming Investor Conferences

Nov 25, 2025, 7:00 AM EST - 4 weeks ago

Bio-Techne to Present at Upcoming Investor Conferences


Bio-Techne Releases First Quarter Fiscal 2026 Results

Nov 5, 2025, 6:30 AM EST - 7 weeks ago

Bio-Techne Releases First Quarter Fiscal 2026 Results


BIO-TECHNE DECLARES DIVIDEND

Nov 5, 2025, 6:30 AM EST - 7 weeks ago

BIO-TECHNE DECLARES DIVIDEND


Bio-Techne Corporation (TECH) Q4 2025 Earnings Call Transcript

Aug 6, 2025, 12:52 PM EDT - 5 months ago

Bio-Techne Corporation (TECH) Q4 2025 Earnings Call Transcript


Bio-Techne Releases Fourth Quarter Fiscal 2025 Results

Aug 6, 2025, 6:30 AM EDT - 5 months ago

Bio-Techne Releases Fourth Quarter Fiscal 2025 Results


Bio-Techne Announces Exosome Diagnostics Divestiture

Aug 5, 2025, 4:30 PM EDT - 5 months ago

Bio-Techne Announces Exosome Diagnostics Divestiture


Bio-Techne to Present at Investor Conferences

May 29, 2025, 7:00 AM EDT - 7 months ago

Bio-Techne to Present at Investor Conferences


Bio-Techne Corporation (TECH) Q3 2025 Earnings Call Transcript

May 7, 2025, 10:38 AM EDT - 8 months ago

Bio-Techne Corporation (TECH) Q3 2025 Earnings Call Transcript


NuNavigator
NuNavigator Dec. 26 at 6:40 AM
$TECH This name increasingly trades on execution rhythm rather than speculation about possibilities. Governance alignment matters more at this stage. Operational wins could gradually shift expectations upward. Execution precision is the primary catalyst from here.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 2:34 PM
$TECH: Current market context shows a bearish trend, with the last close at $59.19 and an RSI of 33.58 indicating oversold conditions. The price is below both the 30-day MA of $60.51 and the 50-day MA of $60.97, reinforcing the downward bias. The 60-day high of $66.96 and low of $54.20 highlight a significant range, suggesting potential for a rebound. Actionable Trade Alert: - Suggested Entry: $59.50 (slightly above last close to confirm upward movement) - Stop Loss: $54.00 (below the 60D low for risk management) - Take Profit Targets: 1. $62.00 (10% ROI) 2. $64.00 (approximately 12.5% ROI) 3. $69.00 (16.5% ROI) With the ATR at $1.86, the targets are achievable within the volatility range. A potential rebound from oversold conditions could drive price towards these targets. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 25 at 9:12 AM
$TECH RSI: 33.58, MACD: -0.6960 Vol: 2.57, MA20: 60.47, MA50: 60.93 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 4:28 PM
$TECH: The current market context shows a stock trading at $57.1, significantly below its 60D high of $66.96, indicating potential for upward movement. The RSI at 23.05 suggests the stock is oversold, which typically signals a reversal opportunity. The 30-day moving average (MA30) at $60.39 and the 50-day moving average (MA50) at $61.00 further support a bullish bias as the price is below these averages, indicating potential resistance levels. Actionable Trade Plan: - Suggested Entry: $57.1 - Stop Loss: $54.0 (3.8% below entry) - Take Profit Targets: 1. $61.0 (6.8% gain) 2. $64.0 (12.5% gain) 3. $66.0 (15.8% gain) With a focus on the potential for a rebound given the oversold RSI and proximity to resistance levels, this trade plan aims for a minimum of 15.8% ROI at the third target. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 3:15 AM
$TECH: Current market context shows a significant downward pressure with the last close at $57.44, and an RSI of 21.06 indicating oversold conditions. The stock is trading below its 30-day MA of 60.62 and 50-day MA of 61.11, suggesting a bearish trend. However, the extreme RSI indicates a potential reversal opportunity. Directional bias leans towards a bullish reversal given the oversold RSI and proximity to the 60D low of $50.13. Suggested entry point is at $57.44. Set a stop loss at $54.00 to manage risk. Take profit targets are as follows: 1. TP1 at $60.00 (5% gain) 2. TP2 at $63.00 (10% gain) 3. TP3 at $67.00 (16.67% gain) Target 3 provides a potential ROI of over 17%. Monitor price action closely for signs of reversal. Trade Plan: Buy at $57.44, SL at $54.00, TP1 at $60.00, TP2 at $63.00, TP3 at $67.00. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 15 at 6:48 AM
$TECH: Current market context shows a recent close at $58.51, with an RSI of 41.33 indicating potential for upward momentum as it is below 50. The stock is trading below its 30-day MA of 60.88 and 50-day MA of 61.29, suggesting bearish sentiment in the short term. However, the price is closer to the 60-day low of 50.13, indicating a potential rebound opportunity. Directional bias leans bullish as the stock may be due for a correction towards its recent highs. Suggested entry is at $58.51. Set a stop loss at $56.46 (1 ATR below the entry). Take Profit Targets: 1. TP1 at $60.00 (4% gain) 2. TP2 at $62.00 (6.5% gain) 3. TP3 at $68.50 (17% gain) This trade plan provides a clear path with a risk-reward ratio favorable for potential gains, especially with the third target achieving over 17% ROI. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 11 at 11:42 PM
$TECH Trade Alert: Market Context: The last close was $60.59, with an RSI of 55.13 indicating a neutral momentum, suggesting potential for upward movement. The stock is currently trading below its 30-day (MA30) and 50-day moving averages (MA50), which are at $60.97 and $61.37 respectively. The 60-day high of $66.96 provides a resistance level, while the low of $50.13 serves as a support level. Directional Bias: Given the RSI is above 50 but below 60, and the proximity to the MA30, we anticipate a bullish trend as it approaches the moving averages. Trade Plan: - Suggested Entry: $60.75 (slightly above last close) - Stop Loss: $58.00 (below recent support) - Take Profit Targets: - Target 1: $63.00 (5% gain) - Target 2: $65.00 (7.5% gain) - Target 3: $71.00 (17% gain) This plan allows for a structured approach with a favorable risk-reward ratio. https://privateprofiteers.com
0 · Reply
JackDarwin
JackDarwin Dec. 11 at 1:26 PM
$TECH Bullish Tweezer Candlestick Pattern Formed
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Dec. 11 at 11:41 AM
$TECH Bio-Techne's Lunaphore Collaborates With Wyss Center For Bio And Neuroengineering To Develop Automated Workflow For Simultaneous RNA And Protein Detection In 3D Specimens
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 3:45 AM
$TECH: Current market context shows the last close at $58.82, with an RSI of 51.95 indicating neutral momentum. The price is below both the 30-day MA of $61.12 and the 50-day MA of $61.25, suggesting a bearish trend in the short term. However, the price is also above the 60-day low of $50.13, providing a potential support level. Directional bias leans slightly bearish due to the moving averages, but the neutral RSI suggests potential for a reversal. Suggested trade plan: - Entry: $58.82 - Stop Loss: $56.74 (1 ATR below entry) - Take Profit Targets: 1. $61.00 (3.73% gain) 2. $63.00 (7.43% gain) 3. $68.50 (16.52% gain) Target 3 offers a potential ROI of over 17%. Monitor the price action closely as it approaches these levels. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 8 at 11:33 PM
$TECH Trade Alert: Market Context: $TECH is currently trading at $60.83, showing bullish potential as it is above the 30-day (61.32) and 50-day (61.13) moving averages. The RSI at 57.1 indicates a neutral to slightly bullish sentiment, suggesting room for upward movement. Directional Bias: The recent price action is positioned between the 60-day high of 66.96 and low of 50.13, indicating a bullish trend is possible. The ATR of 2.06 suggests moderate volatility, allowing for reasonable price movement. Trade Plan: - Suggested Entry: $61.00 - Stop Loss: $58.00 (3.3% below entry) - Take Profit Targets: 1. $63.00 (3.3% gain) 2. $65.00 (6.6% gain) 3. $71.00 (16.4% gain) Target 3 offers a potential ROI of 17%+. Monitor price action closely and adjust stop loss to lock in profits as targets are hit. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 2:33 AM
$TECH Trade Alert: Market Context: $TECH is currently trading at $63.54, showing resilience near the upper range of its 60-day high of $66.96. The RSI at 59.28 indicates bullish momentum, suggesting that the stock is not overbought yet. Directional Bias: The stock is above the 30-day MA of 61.64 and the 50-day MA of 60.73, indicating a bullish trend. The recent price action is supported by the upward momentum, with potential for further gains. Trade Plan: - Suggested Entry: $63.54 - Stop Loss: $61.00 (below recent support) - Take Profit Targets: 1. $65.00 (approx. 2.3% gain) 2. $67.00 (approx. 5.8% gain) 3. $74.50 (approx. 17.3% gain) The third target aligns with a significant upside potential, leveraging the stock's recent high. Monitor the ATR of 2.01 for volatility management. Execute this plan to capitalize on the bullish trend. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 10:08 PM
$TECH Trade Alert: Market Context: $TECH is currently trading at $63.54, showing resilience near the upper range of its 60-day high of $66.96. The RSI at 59.28 indicates bullish momentum, suggesting that the stock is not overbought yet. Directional Bias: The stock is above the 30-day MA of 61.64 and the 50-day MA of 60.73, indicating a bullish trend. The recent price action is supported by the upward momentum, with potential for further gains. Trade Plan: - Suggested Entry: $63.54 - Stop Loss: $61.00 (below recent support) - Take Profit Targets: 1. $65.00 (approx. 2.3% gain) 2. $67.00 (approx. 5.8% gain) 3. $74.50 (approx. 17.3% gain) The third target aligns with a significant upside potential, leveraging the stock's recent high. Monitor the ATR of 2.01 for volatility management. Execute this plan to capitalize on the bullish trend. https://privateprofiteers.com
0 · Reply
OptionRunners
OptionRunners Dec. 5 at 8:25 PM
$TECH buyer of the January 16th 2026 $60/$55/$75 bear seagulls 5,000 times for $1.22
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 4 at 1:22 PM
$TECH Current Stock Price: $63.85 Contracts to trade: $65 TECH Dec 19 2025 Call Entry: $1.47 Exit: $2.85 ROI: 94% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Dec. 2 at 10:51 AM
0 · Reply
smartkarma
smartkarma Nov. 28 at 6:07 AM
$TECH | Bio-Techne Braces for a Biotech Funding Revival—Is a Major Upswing Ahead? "Bio-Techne delivered its first-quarter fiscal year 2026 results amidst a challenging market environment. Despite the company’s strategic and..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/bio-techne-braces-for-a-biotech-funding-revival-is-a-major-upswing-ahead
0 · Reply
smartkarma
smartkarma Nov. 28 at 6:02 AM
$TECH | Bio-Techne Braces for a Biotech Funding Revival—Is a Major Upswing Ahead? "Bio-Techne delivered its first-quarter fiscal year 2026 results amidst a challenging market environment. Despite the company’s strategic and..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/bio-techne-braces-for-a-biotech-funding-revival-is-a-major-upswing-ahead
0 · Reply
SPYmyQQQ
SPYmyQQQ Nov. 24 at 7:53 PM
🎯 Target Hit 🏁 📨 From Nov 12, 2025 🏛️ $TECH 💵 Entry: $61.3900 ✅ Exit: $63.1028 💰 P/L: +2.79% 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 23 at 5:50 PM
0 · Reply
JarvisFlow
JarvisFlow Nov. 20 at 2:13 PM
Argus Research has updated their rating for Bio-Techne ( $TECH ) to Buy with a price target of 68.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Nov. 14 at 4:03 PM
$TECH RSI: 32.64, MACD: 0.0440 Vol: 2.51, MA20: 61.66, MA50: 58.10 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply